Clinical trials: Competence
Neoplasms
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
This trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.
- Trial name
- NCT03391778
- Testing
- ADP adoptive cell therapy
- Where
- 24 sites in United States, Australia and 6 more
- Volunteers
- 250 people
- Sponsor
- USWM CT, LLC
Curtural Humility Training Among Expart Nurses
The Effectiveness of Simulated Cultural Humility Training on Nurse's Ability to Provide Culturally Competent Care and Patient Satisfaction in HMC, Doha, Qatar.
Globalization has significantly increased cultural diversity across many countries. Cultural diversity has been identified as an important factor influencing disease progression and health outcomes.
- Trial name
- culture (NCT07618091)
- Testing
- Simulated Cultural Humility Training
- Where
- Qatar
- Volunteers
- 100 people
- Sponsor
- Hamad Medical Corporation
Malaria Falciparum, Malaria Infection
Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
This is a first-in-humans randomized, double-blind, placebo-controlled, age de-escalation Phase 1 trial of Plasmodium falciparum (Pf) late liver stage-arresting replication-competent (LARC) sporozoite (SPZ) malaria vaccine…
- Trial name
- NCT06652737
- Testing
- PfSPZ-LARC2 Vaccine
- Where
- Burkina Faso
- Volunteers
- 75 people, healthy volunteers welcome
- Sponsor
- Sanaria Inc.